解密九州通现象(Decryption of Kyushu phenomenon).docVIP

解密九州通现象(Decryption of Kyushu phenomenon).doc

  1. 1、本文档共10页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
解密九州通现象(Decryption of Kyushu phenomenon)

解密九州通现象(Decryption of Kyushu phenomenon) In August 20, 2010, the largest private enterprises in Hubei, the top three domestic pharmaceutical logistics enterprises -- Kyushu Pharmaceutical Group successfully pass through the domestic capital market: IPO (IPO) application was reviewed by the Commission, will visit the Shanghai Stock exchange. Since 2005, Hubeis first listed on the main board of the enterprise will become it. As the pharmaceutical industry leader, Jointown is a western medicine, Chinese medicine and medical equipment wholesale, logistics, retail and e-commerce as the core business of the joint-stock enterprises, is one of the countrys three largest commercial pharmaceutical circulation enterprises. The Jointown intends to issue not more than 150 million shares, the total issued share capital of not more than 1 billion 420 million shares. According to the prospectus, the companys actual controller Liu Baolin held 691 million shares in total. In addition, Liu Baolins brother, Liu Shulin Liu Zhaonian, son of Liu Dengpan and the company manager, the backbone of the company staff of 63 natural person holding company stock. Currently in a quiet period before the listing, many things can not say. Kyushu Pharmaceutical Group Chairman Liu Baolin told the Chinese new era on the phone. In 2009, Jointown Pharmaceutical Group sales revenue of 18 billion 900 million yuan, is the largest private enterprises in Hubei Province, in third, Chinese private pharmaceutical commercial enterprises ranked first in the national 10000 pharmaceutical commercial enterprises, has been nominated for 6 consecutive years Chinese top 500 enterprises. As of 2009, the companys total assets of about 7000000000 yuan, more than 70 subordinate enterprises, net profit of 303 million yuan, 0.25 yuan per share. The Great Wall securities analyst Yin Xiong believes that the ratio is calculated by listed pharmaceutical companies an average of 40 times earnings, Jointown issue price of 10 yuan in t

您可能关注的文档

文档评论(0)

jgx3536 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:6111134150000003

1亿VIP精品文档

相关文档